JBIO

Conviction 100HealthcareScan · Fri, Jun 26, 2026

Bullish harami

JBIO$22.00+0.87%

ResistanceSupportVol 14

Vol MA14 1.66M

Mar 27Apr 15May 4May 20Jun 9Jun 26

Jade Biosciences, Inc.PHARMACEUTICAL PREPARATIONSwww.jadebiosciences.com ↗

Price22.00

Change+0.87%

Gap+0.55%

Rel volume2.08×

Avg volume1.74M

Avg $ vol31.36M

SMA 2017.95

SMA 5021.49

SMA 20015.00

Price vs 50+2.37%

Price vs 200+46.69%

MA stackbullish

50/200 cross—

Supertrendup · 16.91

RSI (14)62

MACD hist0.87

MACD crossbull · 4d

Stoch %K / %D84 / 83

ADX (14)33

+DI / −DI27 / 17

RSI divergence—

MACD divergence—

ATR %+8.03%

ADR %9.60%

52w high26.85

52w low6.77

From 52w high-18.06%

Above 52w low+224.96%

New 52w highNo

SqueezeOff

Bollinger width55.05%

%B0.91

Donchian pos83.82%

Donchian high23.49

Donchian low14.28

AVWAP (52w high)19.63

vs AVWAP high+12.10%

AVWAP (52w low)17.05

vs AVWAP low+29.03%

OBV trendFlat

Chaikin MF (20)-0.07

Today vs 20d2.08×

Avg vol (14d)1.66M

Avg vol (20d)1.74M

Avg $ vol (20d)31.36M

Market cap—

RS 3m (vs SPY)+44.55%

RS 6m (vs SPY)+22.06%

RS line new highNo

Trend template8/8

Technical rank82.9

1 week+30.80%

1 month+2.33%

3 months+57.71%

6 months+34.56%

1 year+109.32%

YTD+55.37%

P/E-8.45

P/B3.63

P/S—

P/FCF-11.34

EPS-3.19

Div yield—

ROE-42.98%

ROA-39.89%

Debt/Eq—

Current14.29

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth-82.99%

Price target48.50

Target upside122.48%

Analyst ratingBuy

Institutional85.57%

Ent. value1.02B

Revenue—

Net income-40.37M

Gross profit—

Free cash flow-94.89M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out49.36M

Employees55

ListedTue, Apr 29, 2025

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeA+

Conviction100 / 100

Pattern quality—

Tech rank82.9 / 100

Group rank50 / 100

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmBullish harami

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in JBIO

All disclosures →

No recent disclosed trades by Congress in JBIO. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in JBIO

No recent insider (Form 4) filings in JBIO. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in JBIO · 7 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.